Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
New orally available compounds...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)
Bibliographic Details
Main Authors:
Fairclough, R
,
Guiraud, S
,
Squire, SE
,
Babbs, A
,
Edward, B
,
Shah, N
,
Bracchi, A
,
Wilson, F
,
Horne, G
,
Robinson, N
,
Araujo, N
,
Hewings, D
,
Vuorinen, A
,
Davies, S
,
Wynne, G
,
Russell, A
,
Tinsley, J
,
Davies, K
Format:
Conference item
Published:
2014
Holdings
Description
Similar Items
Staff View
Similar Items
Utrophin in the therapy of Duchenne Muscular Dystrophy
by: Potter, A, et al.
Published: (2006)
Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD)
by: Tinsley, J, et al.
Published: (2013)
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)
Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2012)
Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
by: Fairclough, R, et al.
Published: (2008)